A Phase 1b/2 Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Condition: Pulmonary Sarcoidosis Intervention: Drug: XTMAB-16 or Placebo Sponsor: Xentria, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials